Takeda makes some pipeline cuts, says generic competition softened sales over last six monthsnews2025-10-30T11:09:35+00:00October 30th, 2025|Endpoints News|
Lilly blows past revenue benchmarks, again raises full-year outlooknews2025-10-30T11:09:02+00:00October 30th, 2025|Endpoints News|
Novo Nordisk proposes to acquire Metsera in bid to disrupt Pfizer’s dealnews2025-10-30T10:16:25+00:00October 30th, 2025|Endpoints News|
Roche promises $1B to China biotech for preclinical COPD bispecificnews2025-10-30T01:48:30+00:00October 30th, 2025|Endpoints News|
Thermo Fisher to buy data solutions-focused Clario for up to $9.4Bnews2025-10-29T18:49:39+00:00October 29th, 2025|Endpoints News|
GSK confirms it has completed IRA negotiations ahead of CMS deadlinenews2025-10-29T17:54:46+00:00October 29th, 2025|Endpoints News|
Lilly budgets $1.2B for GLP-1 pill factory in Puerto Rico news2025-10-29T17:38:18+00:00October 29th, 2025|Endpoints News|
What Novo Nordisk might be planning to turn the ship aroundnews2025-10-29T15:23:20+00:00October 29th, 2025|Endpoints News|
Novo Nordisk’s direct-to-patient platform gains momentum as self-pay sales risenews2025-10-29T15:23:01+00:00October 29th, 2025|Endpoints News|
